Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 15/20 | 1.00 |
| ▸ | CDC25B | P30305 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | CASP6 | P55212 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL321637 | 0.98 | HCAR3 (0.97) | HCAR3CDC25BMEN1KMT2ACASP6 | |
| SCHEMBL973813 | 0.87 | HCAR3 (0.77) | HCAR3CDC25BMEN1KMT2A | |
| SCHEMBL2248642 | 0.87 | HCAR3 (0.77) | HCAR3CDC25BMEN1KMT2ACASP6 | |
| SCHEMBL10665446 | 0.85 | HCAR3 (0.74) | HCAR3CDC25BKMT2A | |
| SCHEMBL2253159 | 0.85 | HCAR3 (0.74) | HCAR3CDC25BMEN1KMT2A | |
| SCHEMBL506550 | 0.85 | HCAR3 (0.74) | HCAR3CDC25BMEN1KMT2A | |
| SCHEMBL11269607 | 0.84 | CDC25B (0.78) | HCAR3CDC25B | |
| SCHEMBL7376176 | 0.84 | CDC25B (1.00) | HCAR3CDC25BMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL18813442 | 0.84 | HCAR3 (0.72) | HCAR3CDC25BMEN1KMT2A | |
| SCHEMBL3613079 | 0.84 | HCAR3 (0.72) | HCAR3MEN1KMT2ACASP6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684227-A | The method comprises the following steps of18Synthesis method of F-fluoromethol labeling precursor | 国电投核素同创(重庆)科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| EP-2834224-B1 | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND SALTS THEREOF | MSN LAB LTD (IN) | 2018-06-06 | — | — | EP | claimed |
| CN-104356022-B | A kind of synthetic method of N-methyl-4-(methylamino)-3-nitrobenzamide | 上海应用技术学院 | 2016-06-08 | — | — | CN | claimed |
| WO-2015128875-A2 | A PROCESS FOR PREPARATION OF DABIGATRAN ETEXILATE MESYLATE AND INTERMEDIATES THEREOF | MEGAFINE PHARMA (P) LTD. (IN) | 2015-09-03 | — | — | WO | claimed |
| US-20150087842-A1 | Process For The Preparation Of Benzimidazole Derivatives And Salts Thereof | MSN LABORATORIES PRIVATE LIMITED (IN) | 2015-03-26 | — | — | US | claimed |
| CN-104356022-A | Synthetic method of N-methyl-4-(methyl amino)-3-nitrobenzamide | SHANGHAI INST TECHNOLOGY | 2015-02-18 | — | — | CN | claimed |
| EP-2834224-A2 | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND SALTS THEREOF | MSN Laboratories Limited (IN) | 2015-02-11 | — | — | EP | claimed |
| US-20150011589-A1 | PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE MESYLATE AND POLYMORPHS OF INTERMEDIATES THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2015-01-08 | — | — | US | claimed |
| CN-104230888-A | Preparation method of benzimidazole compound | UNIV CHANGCHUN TECHNOLOGY | 2014-12-24 | — | — | CN | claimed |
| CN-104130185-A | Method for preparing pradaxa intermediate | BENGBU BBCA MEDICINE SCIENCE & DEV CO LTD | 2014-11-05 | — | — | CN | claimed |
| WO-2013150545-A2 | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND SALTS THEREOF | MSN LABORATORIES LIMITED (IN) | 2013-10-10 | — | — | WO | claimed |
| WO-2013111163-A2 | PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE MESYLATE AND POLYMORPHS OF INTERMEDIATES THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2013-08-01 | — | — | WO | claimed |
| WO-2013024384-A1 | IMPROVED PROCESS FOR PREPARATION OF DABIGATRAN ETEXILATE AND ITS NOVEL INTERMEDIATE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2013-02-21 | — | — | WO | claimed |
| EP-0170069-B1 | HAIR-DYEING COMPOSITIONS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1989-10-11 | — | — | EP | claimed |
| EP-0170069-A1 | Hair-dyeing compositions | Henkel Kommanditgesellschaft auf Aktien (DE) | 1986-02-05 | — | — | EP | claimed |
| WO-2026106403-A1 | NOVEL NRF2 ACTIVATOR AND USE THEREOF | 나손사이언스(주) | 2026-05-21 | — | — | WO | disclosed |
| CN-119684227-A | The method comprises the following steps of18Synthesis method of F-fluoromethol labeling precursor | 国电投核素同创(重庆)科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-0127897-A2 | Photographic products and processes | POLAROID CORPORATION (US) | 1984-12-12 | — | — | EP | disclosed |
| US-4468448-A | COLORLESS DYE PRECURSOR CONTAINING A 1,3-SULFUR-NITROGEN GROUP THAT UNDERGOES CLEAVAGE | POLAROID CORPORATION (US) | 1984-08-28 | — | — | US | disclosed |
| US-4468451-A | 2-AMIDOTHIAZOLINE | POLAROID CORPORATION (US) | 1984-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087842-A1 | Process For The Preparation Of Benzimidazole Derivatives And Salts Thereof | AZI2, IL4I1, ABAT | HCAR3 3963/4885CDC25B 1071/4885MEN1 3323/4885 |
| US-20150011589-A1 | PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE MESYLATE AND POLYMORPHS OF INTERMEDIATES THEREOF | CYP1A2, CYP3A4, CYP2C9 | HCAR3 3277/4885CDC25B 508/4885MEN1 2233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.